This is just the beginning! Our collection holds over 300 years of history, including rare newspapers, obituaries, marriage records, birth records, and so much more—most of which you won’t find anywhere else!
FDA approves interchangeable biosimilar insulin swap
U.S. regulators approve Viatris and Biocon Semglee as interchangeable with Lantus, enabling pharmacists to substitute a cheaper near-copy insulin at the counter. The move could save patients and plans millions yearly, with a second interchangeable long acting insulin expected soon.
MENTIONED IN THIS ARTICLE
U.S
Food and Drug Administration
FDA
IQVIA
Viatris Inc
Semglee
Viatris
India
Biocon
Mylan M
Europe
Sean McGowan
AmerisourceBergen
Lantus
J. Omar Ornelas
Palm Springs
Desert Sun